Distinct Genomic Alterations in Prostate Cancers in Chinese and Western Populations Suggest Alternative Pathways of Prostate Carcinogenesis
Authors:
- Yongwei YuYYYongwei Yu
- Lara K. BoydLBLara K. Boyd
- Guoping RenGRGuoping Ren
- Dongmei LinDLDongmei Lin
- Tracy ChaplinTCTracy Chaplin
- Sakunthala C. KudahettiSKSakunthala C. Kudahetti
- Elzbieta StankiewiczESElzbieta Stankiewicz
- Liyan XueLXLiyan Xue
- Luis BeltranLBLuis Beltran
- Manu GuptaMGManu Gupta
- R. Tim D. OliverROR. Tim D. Oliver
- 30 June 2010
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 70 (13) , 5207-5212
Abstract
Prostate cancer is significantly more common in Western men than in Asian men, but the basis for this difference remains unknown. Because genomic studies of Asian prostate cancer are very limited, we used a genome-wide approach to reveal the genomic alterations in Chinese prostate cancers. We found a significant reduction in the frequency of certain somatic genomic changes that are commonly found in Western prostate cancers, including the 21q22.2-22.3 deletion, which involves the TMPRSS2:ERG fusion gene, and 10q deletion, which causes PTEN inactivation. Array results were confirmed by PCR-based molecular copy-number counting in selected samples. The different frequencies of these genomic changes were further evaluated by fluorescent in situ hybridization and immunohistochemistry analyses of tissue microarray samples. These alterations might be key genetic changes underlying the regional/ethnic difference in clinical incidence and might be induced by specific environmental and/or genetic risk factors that Western men are exposed to. Our findings suggest that tumors arise in Western and Chinese populations by alternative pathogenetic mechanisms. Cancer Res; 70(13); 5207–12. ©2010 AACR.Keywords
All Related Versions
This publication has 20 references indexed in Scilit:
- Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progressionLaboratory Investigation, 2009
- Rapid high‐resolution karyotyping with precise identification of chromosome breakpointsGenes, Chromosomes and Cancer, 2007
- The impact of translocations and gene fusions on cancer causationNature Reviews Cancer, 2007
- Integrative molecular concept modeling of prostate cancer progressionNature Genetics, 2006
- TMPRSS2:ERG Fusion-Associated Deletions Provide Insight into the Heterogeneity of Prostate CancerCancer Research, 2006
- Comprehensive assessment of DNA copy number alterations in human prostate cancers using Affymetrix 100K SNP mapping arrayGenes, Chromosomes and Cancer, 2006
- Interrogation of genomes by molecular copy-number counting (MCC)Nature Methods, 2006
- Akt-regulated pathways in prostate cancerOncogene, 2005
- Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate CancerScience, 2005
- Prostate cancer epidemiologyThe Lancet, 2003